| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 07/14/2005 | US20050153366 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
| 07/14/2005 | DE10360369A1 Amide Amides |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1553074A1 Fused benzene derivative and use |
| 07/13/2005 | EP1551799A1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 07/13/2005 | EP1551798A1 Novel sulphones for inhibition of gamma secretase |
| 07/13/2005 | EP1551511A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 07/13/2005 | EP1427711B1 Oxazolidinone and/or isoxazoline derivatives as antibacterial agents |
| 07/13/2005 | EP1144364B1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/13/2005 | CN1639160A Process for preparing crystalline form I of cabergoline |
| 07/13/2005 | CN1639136A Oxazolidinone and/or isoxazoline as antibacterial agents |
| 07/13/2005 | CN1639135A N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials |
| 07/13/2005 | CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 07/13/2005 | CN1636994A Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1210269C Preparation of 4-trioalkylbromobenzene derivatives |
| 07/13/2005 | CN1210028C Aqueous liquid preparation |
| 07/07/2005 | WO2005061477A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | WO2005061459A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | WO2005060456A2 Method for treating adamts-5-associate disease |
| 07/07/2005 | US20050148648 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators |
| 07/07/2005 | US20050148638 Increasing contractile force in cardiac muscle fiber by administering a N-[(3-yloxy)-phenyl]-arylamide derivatives; modulating at the cardiac sarcomere (cardiac beta myosin) for congestive heart failure |
| 07/07/2005 | US20050148605 Modulation of protein tyrosine kinases for treatment of diseases with prodrugs |
| 07/07/2005 | DE10357301A1 Verbindungen zur Modulation des Glykolyse-Enzym- und/oder Transaminase-Komplexes Compounds for modulation of the glycolytic enzyme and / or transaminase complex |
| 07/07/2005 | CA2548518A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | CA2548513A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | CA2547575A1 Method for treating adamts-5-associated disease |
| 07/06/2005 | EP1550658A1 Method for preparing 3,4-diphenyl-substituted isoxazole compounds |
| 07/06/2005 | EP1550461A1 Remedy for chronic disease |
| 07/06/2005 | EP1549613A1 Sulfonamides having antiangiogenic and anticancer activity |
| 07/06/2005 | CN1636002A Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide |
| 07/06/2005 | CN1635979A IL-8 receptor antagonists |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058845A2 Novel glucagon antagonists/inverse agonists |
| 06/30/2005 | WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 06/30/2005 | WO2002058698A8 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 06/30/2005 | US20050143583 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 06/30/2005 | US20050143434 Or Benzo(d)isothiazol-3-ols, O-alkyl derivatives and aluminum, calcium, lithium, magnesium, potassium, sodium, and zinc salts; enhancing learning, memory and/or cognition and treating ataxia, neuropathic pain or for preventing loss of neuronal function characteristic of neurodegenerative diseases |
| 06/30/2005 | US20050143433 Substituted heterocycles useful for treating HCV infection |
| 06/30/2005 | US20050143432 Crystallization in solvent dimethyl formamide; x-ray powder diffraction pattern; cyclooxygenase-2 enzyme inhibitor useful for the treatment of arthritis and pain |
| 06/30/2005 | US20050143431 Novel crystalline forms of parecoxib sodium |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143422 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/30/2005 | US20050143379 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2491332A1 Method for preparing diaryl-substituted isoxazole compounds |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | CN1633412A Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/29/2005 | CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 06/29/2005 | CN1208176C Homogenization enhancing thermoplastic foam extrusion screw |
| 06/23/2005 | WO2005057171A2 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
| 06/23/2005 | WO2005056540A1 Heterocyclic substituted indane derivatives and related compounds for the treatment of schizophrenia |
| 06/23/2005 | WO2005055715A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 06/23/2005 | WO2005040121A3 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 06/23/2005 | WO2005033056A3 Triphenylethylene compounds as selective estrogen receptor modulators |
| 06/23/2005 | US20050137212 Hppars activators |
| 06/23/2005 | US20050137200 Potassium channel modulators; antiarrhythmia agents |
| 06/23/2005 | US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels |
| 06/23/2005 | CA2548447A1 Heterocyclic substituted indane derivatives and related compounds for the treatment of schizophrenia |
| 06/22/2005 | EP1542967A1 Amide and sulfonamide ligands for the estrogen receptor |
| 06/22/2005 | EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases |
| 06/22/2005 | CN1630633A N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/21/2005 | US6908923 Compositions and methods for treating heart failure |
| 06/16/2005 | WO2005054213A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
| 06/16/2005 | WO2005054204A2 Pharmaceutical compounds that regenerate in vivo |
| 06/16/2005 | WO2005054179A2 Hydroxamic acid esters and pharmaceutical use thereof |
| 06/16/2005 | WO2005054174A2 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex |
| 06/16/2005 | US20050131036 E.g., 5-(5-ethyl-2-hydroxy-4-methoxyphenyl)-4-(4-methoxyphenyl)isoxazole, 5-(2,4-dimethoxy-5-ethylphenyl)-4-(4-bromophenyl)isoxazole or 5-(2,4-dihydroxy-5-etylphenyl)-4-(4-hydroxyphenyl)isoxazole, used for treating cancer cell migration, rheumatoid arthritis, psoriasis or other angiogenesis diseases |
| 06/16/2005 | US20050131018 Acetylene derivatives as inhibitors of histone deacetylase |
| 06/16/2005 | US20050130973 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/16/2005 | CA2549242A1 Hydroxamic acid esters and pharmaceutical use thereof |
| 06/15/2005 | EP1539697A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 06/15/2005 | EP1539685A1 Mcp-1 receptor antagonists and method of use thereof |
| 06/15/2005 | EP1539143A2 Leflunomide analogs for treating rheumatoid arthritis |
| 06/15/2005 | EP1373240B1 Retinoid x receptor modulators |
| 06/14/2005 | US6906072 Central nervous system disorders |
| 06/14/2005 | US6906070 Anticoagulants |
| 06/09/2005 | WO2005051932A1 Arylheterocycle derivative and agricultural or horticulrual bactericide and insecticide |
| 06/09/2005 | WO2005051931A2 Phosphodiesterase inhibitors |
| 06/09/2005 | WO2005051385A1 Substituted heterocycles useful for treating hcv infection |
| 06/09/2005 | WO2005040142A9 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
| 06/08/2005 | EP1538150A1 Novel pleuromutilin derivatives |
| 06/08/2005 | EP1538138A1 Substituted benzanilide compound and pest control agent |
| 06/08/2005 | EP1537124A1 C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
| 06/08/2005 | EP1537077A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties |
| 06/08/2005 | EP1536790A2 Oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 06/08/2005 | EP1465854A4 Chalcone derivatives and their use to treat diseases |
| 06/08/2005 | CN1623988A Biaryl sulfonamides and methods for using same |
| 06/08/2005 | CN1623537A Biaryl sulfonamides and its using method |
| 06/08/2005 | CN1205193C Crystalline form of 4-[5-methyl-3-phenylisoxazol)-4-yl] benzenesulfonamide |
| 06/08/2005 | CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |